Location History:
- Taipei 105, TW (2009)
- Taipei, TW (1999 - 2023)
Company Filing History:
9 out of 685 
1 out of 71 
1 out of 1 
Years Active: 1999-2023
Title: The Innovative Contributions of Shui-Tein Chen
Introduction
Shui-Tein Chen is a distinguished inventor based in Taipei, Taiwan, recognized for his significant contributions to the field of biotechnology. He holds a remarkable total of 13 patents, showcasing his commitment to innovation and research that addresses critical health issues.
Latest Patents
Among his latest notable patents, the "Anti-GM2AP antibody and applications thereof" stands out. This invention discloses a recombinant antibody or its antigen-binding fragment that specifically binds to GM2-activator protein (GM2AP). The patent includes details on polynucleotides encoding these antibodies, the vectors used, host cells, kits for detecting GM2AP, and methods for inducing these antibodies. Another significant patent is related to a lung cancer biomarker which aids in the early diagnosis and prognosis prediction of lung cancer by utilizing the GM2AP protein. This innovation brings hope for earlier detection and better patient outcomes in lung cancer cases.
Career Highlights
Shui-Tein Chen's career has been marked by his tenures at esteemed institutions, particularly Academia Sinica, where he has contributed to numerous research initiatives. His work in these environments has paved the way for groundbreaking advancements in medical diagnostics and therapeutic interventions.
Collaborations
Collaboration is a cornerstone of innovation, and Shui-Tein Chen has worked alongside esteemed colleagues such as Yuan-Yuan Wang and Kay-Hooi Khoo. These partnerships have enhanced his research capabilities, allowing for the integration of diverse expertise in tackling complex health challenges.
Conclusion
Shui-Tein Chen's inventive spirit and groundbreaking research demonstrate the vital role that inventors play in advancing healthcare solutions. His patents not only address pressing medical needs but also pave the way for future innovations that can significantly impact patients' lives worldwide.